Dr. Roy Pascual Venzon, MD

Dr. Venzon practices at AdventHealth Fish Memorial in Orange City, Florida, part of AdventHealth.

Dr. Venzon's NPI, 1336333681, was assigned on August 29, 2007. Dr. Venzon graduated from University of the Philippines College of Medicine in 2000. Dr. Venzon holds Florida license ME120286.

Dr. Venzon's primary practice is AdventHealth Fish Memorial, at 1055 Saxon Blvd, Orange City, FL 32763 in Volusia County. The practice phone is (386) 917-5000.

Dr. Venzon's primary practice is AdventHealth Fish Memorial in Orange City, Florida, part of AdventHealth. Dr. Venzon is also affiliated with AdventHealth Daytona Beach. The medical group on file is Halifax Health. Dmand AI also links Dr. Venzon to 2 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Venzon practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Venzon's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Venzon is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Venzon's licenses on file in 4 states: Florida, Iowa, Texas and Illinois.

Dmand AI lists angioplasty, cardiac catheterization, endocarditis, leg revascularization, pacemaker or defibrillator implantation and varicose vein treatment among the conditions Dr. Venzon treats.

CMS data shows 4,130 Medicare services from Dr. Venzon across 40 procedure codes in 2024, for 1,443 Medicare patients. Medicare paid $325,156 for them.

CMS counts 1,443 Medicare patients who saw Dr. Venzon in 2024. The largest group is 75 to 84, with 542 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Venzon's median patient age at 73, with 53% women.

In 2024, Dr. Venzon wrote 3,428 Medicare Part D claims for 617 patients. 80% of them were for generic drugs. CMS names the drug for 3,210 of them, across 39 drugs with 11 or more claims each, at $631,484 in total drug cost. In 2023, CMS named 3,008 claims across 37 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Venzon for performance year 2024, reported as part of a group. Dr. Venzon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 46 procedures of coronary angioplasty and stenting by Dr. Venzon, more than 81% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Varicose vein removal: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Venzon in 2013. Dr. Venzon's most frequent co-authors are Charles L. Laham, MD, Matthew J. McMahon, DO and Nicolas W. Shammas, MD.

CMS Open Payments shows 150 general payments to Dr. Venzon from 26 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 53% of the total. Medtronic Vascular, Inc. paid the most, $4,085.

Dmand AI lists 3 awards for Dr. Venzon, most recently ACC Fellow in 2012.

Dr. Venzon graduated from University of the Philippines College of Medicine in 2000. Dr. Venzon is a member of ACC and The Society for Cardiovascular Angiography and Interventions.

Dr. Venzon is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.